Using our AI model trained on historical data, we generated a 12‑month forecast for Agios Pharmaceuticals Inc. (AGIO) stock. The model estimates a median target price of 47—ranging from a low of 30.57 to a high of 63.35—which suggests an increase of 41.69% compared to the current price of 33.17.